<DOC>
	<DOCNO>NCT02380170</DOCNO>
	<brief_summary>The study aim get insight causative bacteria sepsis derive urinary tract . Furthermore , intention understand outcomes patient . For purpose non-interventional , observational study conduct .</brief_summary>
	<brief_title>Epidemiology Outcomes Gram Negative Urosepsis</brief_title>
	<detailed_description>In prospective , non-interventional , observational registry participant diagnose urosepsis register study capture event outcomes interest . There additional intervention evaluation purpose study . -Primary objective : 1 . Pathogens : Causative pathogen susceptibility profile 2 . Clinical outcome : Development organ failure mortality . 3 . Costs : Hospital resource use cost acquire - Secondary objective : 1 . Risk factor : Influence patient characteristic ( medical &amp; urological history , comorbidities ) severity urosepsis ( simple , severe &amp; septic shock ) , causative pathogen profile outcomes 2 . Appropriateness antibiotic treatment : The influence appropriate antibiotic treatment , identified empirical treatment provide pre-treatment culture result , clinical outcome . 3 . Economic evaluation : Identify cost health state change accord appropriateness treatment . -Rationale : Results GPIU registries 2003 2013 show , rate urosepsis `` health-care '' associate infection urological patient increase 15 % 2003 25 % 2013 . This create extra burden health system need good understood detail . Early management urosepsis imperative . An important step management appropriate empirical antibiotic treatment require understanding local global pathogen susceptibility profile . Furthermore , pilot analysis GPIU show individual patient characteristic helpful guide empirical treatment . Appropriate empirical antibiotic treatment show associate well clinical outcome low length stay ( LOS ) . -Objectives The aim registry investigate epidemiology urosepsis primarily Europe , specific examination causative pathogen resistance , associate risk factor , clinical data , cost associate value initial appropriate antimicrobial treatment . 3.1 . Primary objective : - Describe prevalence organism cause urosepsis - Describe susceptibility profile organism cause urosepsis . - Describe clinical economic burden urosepsis cause resistant Gram negative pathogen interest . 3.2 . Secondary objective : - Characterize risk factor infection resistant gram negative pathogens interest . - Examine impact initial inappropriate antibiotic therapy clinical economic outcome . - Design This prospective , longitudinal data collection ancillary registry 2013 Global Prevalence Infections Urology ( GPIU ) point prevalence registry perform annually European Association Urology ( European Section Infection Urology ) . Participating hospital perform data collection goal collect complete hospital course data 600 case urosepsis . The GPIU group handle contracting , data collection , data analysis part registry . - Participants The population observe adult patient clinical diagnosis urosepsis . Observations initiate patient diagnose urosepsis base clinical symptom finding part routine clinic practice emergency accident , urology internal medicine unit . The data bacterial isolates susceptibility result use study obtain part routine clinical care . The necessity inform patient consent discretion participate institution . All patient data analyze anonymously . -Patients observe Identification observation : Patients observe identified emergency accident , urology , intensive care internal medicine unit participate site . Eligibility criterion checklist case consider observe filled participating principal investigator ( PI ) . Clinical information initial diagnosis use ass eligibility . -Observations Diagnosis observation Routine clinical sign symptom assess manage physician use evaluate patient . The following observation carry time diagnosis : - Medical history - Microbiology culture - Clinical sign , symptom finding Treatment observations The following observation register diagnosis initiation treatment : - Medical treatment - Surgical treatment - Treatment unit Post-treatment observation Subsequent initiation treatment follow observation register : • End organ failure - Shift treatment - Mortality Registration carry post diagnosis day 3,7,9 30 capture change within follow time-gaps respectively : - Diagnosis day day 3 - Post diagnosis day 4 7 - Post diagnosis day 8 9 - Post diagnosis day 10 30 For patient treatment extend beyond 30 day additional registration carry change list post-treatment observation . Completion treatment - observation When treatment patient finalize due either complete resolution sepsis death follow observation carry : • Costs ( optional ) - End-organ failure - Mortality - LOS - HRQoL ( optional ) Post diagnosis 1 year follow-up At end 1st year diagnosis center willing register observation fill follow : • Costs ( optional ) • End-organ failure • Mortality • LOS • HRQoL ( optional ) Schedule observation - Baseline : Medical history , Microbiological proof , management urosepsis , HRQoL ( optional ) -Follow-up-1 ( 3rd day post diagnosis ) : Microbiological proof ( additional carry ) , Management urosepsis , Clinical outcomes -Follow-up-2 ( 7th day post diagnosis ) : Microbiological proof ( additional carry ) , Management urosepsis , Clinical outcomes - Follow-up-3 ( 9th day post diagnosis ) : Microbiological proof ( additional carry ) , Management urosepsis , Clinical outcomes - Follow-up-4 ( 30th day post diagnosis ) : Microbiological proof ( additional carry ) , Management urosepsis , Clinical outcomes - Completion treatment related urosepsis episode : Management urosepsis , Clinical outcome , HRQoL ( optional ) , Economic evaluation ( optional ) - Statistical consideration Data measure continuous scale express mean , standard deviation , range , median . Categorical data express count percentages patient category . Chi-square Fisher 's test use test statistical difference categorical variable T- Mann-Whitney test utilized determination statistical difference continuous variable appropriate . - Management The GPIU study team provide support participate center . The secretarial staff EAU-Research foundation provide clerical support study . - Administration , logistics &amp; quality assurance Sharing observation Electronic ( e ) case report form ( CRF ) use collection observational information . EAU-RF study coordinator provide guidance site aid completion eCRFs . The study scientific group reserve right amend add eCRF template appropriate . Such change constitute protocol amendment revise additional form use site . Central data monitoring : After eCRFs complete study site , study coordinator review protocol compliance , inconsistency miss value . Should miss data data abnormality find , query raise resolution site . Any systematic inconsistency identify central data monitoring may subject query . Definition end registry : The end study date last observation capture .</detailed_description>
	<criteria>Microbiologically proven UTI Age &gt; 18 Patients must meet least two follow four SIRS criterion , least one must core temperature criterion WBC criterion ; criterion meet simultaneously : 1 . Hypothermia core temperature &lt; 36ºC , hyperthermia &gt; 38ºC measure via mean 2 . Heart rate ( HR ) &gt; 90 beat per minute 3 . Respiratory rate ( RR ) &gt; 20 breaths/minute relate septic event , partial pressure arterial carbon dioxide ( PaCO2 ) &lt; 32 mmHg relate septic event require mechanical ventilation relate septic event 4 . Total WBC absolute count &gt; 12,000 cells/mm3 presence granulocytestimulating factor , patient whose WBC absolute count &gt; 12,000 cells/mm3 one criterion ( RR HR ) &lt; 4000 cells/mm3 . In , must fever least Sepsis due cause besides urogenital tract .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>sepsis</keyword>
	<keyword>urinary tract infection</keyword>
	<keyword>resistance</keyword>
	<keyword>pathogen</keyword>
	<keyword>mortality</keyword>
	<keyword>health economics</keyword>
</DOC>